NCT03378453
- Conditions
- Alzheimer Disease, Amyloid Pathology, Brain Diseases, +12 more
- Locations
-
- Montpellier University Hospital, Gui de Chauliac Montpellier, France
Clinical trial condition
Neurocognitive Disorders
Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.
7,764 public trials
1,431 recruiting studies
Neurocognitive Disorders trial results
Completed
Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms
NCT03349320
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
Not specified
NCT02462135
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
- Residential care facilities Taipei, Taiwan
NCT01806896
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris, France
NCT01920672
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Completed
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Cognitive Impairment, +13 more
- Locations
-
- Nathan Kline Institute for Psychiatric Research New York, United States
NCT03368482
- Conditions
- Behavior, Cognition Disorders, Cognition Disorders in Old Age, +4 more
- Locations
-
- Fundación San Rosendo Panxón, Pontevedra, Spain
NCT03366896
- Conditions
- Confusion, Delirium, Diagnosis, Psychiatric, +11 more
- Locations
-
Not specified
Completed
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
NCT00710684
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- GSK Investigational Site Litchfield Park, Arizona, United States
- GSK Investigational Site Fresno, California, United States
- GSK Investigational Site Rancho Mirage, California, United States
- GSK Investigational Site San Francisco, California, United States
NCT00458094
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States